Sanofi’s shift to immunology, AI-driven R&D, and strong pipeline offset risks from patent cliffs and legal issues. See why ...

The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...

The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.

On January 16, 2025, Avacta reported encouraging results from its Phase I trial of AVA6000. In patients with salivary gland ...

Bildnachweis: ITM. The radiopharmaceutical industry is entering a new era. Driven by clinical breakthroughs, regulatory ...

In statements to the USA TODAY Network, both the University of Rochester Medical Center, or URMC, and Regeneron noted they ...

Note that some links may require registration or subscription. Experiments showed that the recommended 6 feet of social ...

During a live event, Matthew Lunning, DO, and participants discussed the process of determining if patients with DLBCL should ...